Comparison of erlotinib and pemetrexed as second-/third-line treatment for lung adenocarcinoma patients with asymptomatic brain metastases

Overview of attention for article published in OncoTargets and therapy, April 2016

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 4 Dimensions

Readers on

mendeley: 16 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 260 followers.

Comparison of erlotinib and pemetrexed as second-/third-line treatment for lung adenocarcinoma patients with… https://t.co/Qvp5MTPBmH

Reply Repost Favourite